Skip to main content
HCPCS J2790 · Level II · Part B drug

J2790: rho d immune globulin (Rhogam, HyperRho S/D), HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J2790

Billing unit
300 MCG (1500 IU)
Rho d immune globulin inj
ASP payment limit
$82.081
October 2026; -3.6% vs July 2026
Practitioner MUE
1
MAI 3
OPPS status
SI N
NCCI exposure
0 col-2 pairs
Coverage articles
1
2 states

TL;DR

HCPCS J2790 is the Level II code for Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.), billed per 300 MCG (1500 IU). The Medicare Part B ASP payment limit for October 2026 is $82.081 per billing unit, down 3.6% from July 2026. The practitioner MUE allows up to 1 units per date of service (MAI 3), so a full 1-unit day is $82.08 at the current limit. Under OPPS it carries status indicator N. J2790 is billed in units of 300 MCG (1500 IU); the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. Other HCPCS codes whose descriptor names rho d immune globulin: J2788 (CMS descriptor names "minidose"; billed per 50 mcg (250 IU)); J2792 (Winrho SDF from Kamada Ltd.; intravenous route; billed per 100 IU). The ASP crosswalk maps 5 NDCs to it, sold as Rhogam, HyperRho S/D by Kedrion Biopharma Inc, Grifols USA, LLC. 1 Medicare coverage article lists the code across 2 states, including A57160.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J2790 at $82.081 per 300 MCG (1500 IU) for October 2026, derived from manufacturer average sales price plus 6%, compared with $85.125 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J2790
QuarterPayment limitPerCoinsurance
October 2026$82.081300 MCG (1500 IU)20%
July 2026$85.125300 MCG (1500 IU)—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 5 NDCs from 2 labelers to J2790. Report the NDC in the claim's drug segment and bill the number of J2790 units that equals the quantity administered divided by 300 MCG (1500 IU); the last column gives units per full package.

NDCs that crosswalk to J2790
NDCDrug nameLabelerPackage sizeBilling units / package
00562-7805-01RhogamKedrion Biopharma Inc1 × 11
00562-7805-05RhogamKedrion Biopharma Inc1 × 55
00562-7805-25RhogamKedrion Biopharma Inc1 × 2525
13533-0631-02HyperRho S/DGrifols USA, LLC1 × 11
13533-0631-11HyperRho S/DGrifols USA, LLC1 × 1010

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J2790. For practitioners the limit is 1 unit per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J2790 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services13 Date of Service Edit: ClinicalClinical: Data
Facility outpatient hospital33 Date of Service Edit: ClinicalClinical: Data
DME supplier03 Date of Service Edit: ClinicalCMS Policy

MUE for J2790 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

In the practitioner PTP file v323r0 (effective October 1, 2026), J2790 is the column-2 code in 0 active pairs, and the column-1 code in 2. 0 historical pairs have been deleted over time.

These codes are considered components of J2790 when reported together on the same date of service.

Column-2 codes most often bundled into J2790
Column-2 codePairs
90385 (CPT; descriptor licensed by AMA)1
J2792 Rho(d) immune globulin h, sd1

The counts above are exposure, not answers for a specific claim. Check J2790 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J2790 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

1 current Medicare Administrative Contractor article lists J2790 in their HCPCS tables, covering 2 states. Each article carries the covered and non-covered ICD-10 codes that medical-necessity denials (CARC 50) are adjudicated against.

Billing and Coding Articles listing J2790
ArticleTitleContractor(s)StatesRelated LCD
A57160Billing and Coding: Immune Thrombocytopenia (ITP) TherapyCGS Administrators, LLCKY OHL38268

Diagnoses Medicare contractors cover for J2790

One billing and coding article attaches a covered diagnosis list to J2790: 1 distinct ICD-10-CM code in all. The 1 below come first by how many of those articles cover them, then in the contractor's own order. The claim line is checked against the list of the contractor that processes it, and a diagnosis outside that list is denied as not medically necessary (CARC 50).

First 1 covered ICD-10-CM codes for J2790
ICD-10-CMDescription (FY2027)Articles covering
D69.3Immune thrombocytopenic purpura1 of 1

Contractors split an article's diagnoses into numbered groups and say in each group's instructions which procedure codes it supports. Only the groups that apply to J2790 are counted here. The full list opens on the policy page with every group, the non-covered codes and the instructions.

Covered diagnosis lists that apply to J2790, by article
ArticleContractorGroups that applyCovered codes for J2790Full list
A57160CGS Administrators, LLCone list for every code in the article1On LCD L38268

Local coverage policies that list J2790

1 active Local Coverage Determination lists J2790 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J2790 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J2790 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for J2790 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J2790

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J2790

What does HCPCS code J2790 describe?

J2790 is defined by CMS as "Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)". Each billing unit represents 300 MCG (1500 IU), so the units reported on the claim must equal the dose administered divided by that unit.

Is J2790 a CPT code?

No. J2790 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as rho d immune globulin; CPT codes are five-character codes maintained by the AMA. On a Part B claim J2790 reports the drug itself in 300 mcg (1500 IU) units, and the administration is billed on its own line.

What is the Medicare reimbursement for J2790 in October 2026?

The ASP-based payment limit is $82.081 per 300 MCG (1500 IU), with 20% beneficiary coinsurance. The July 2026 limit was $85.125. Commercial payers use their own fee schedules.

How many units of J2790 can be billed per day?

The practitioner Medically Unlikely Edit is 1 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). The facility outpatient MUE is 3. MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Clinical: Data" as the rationale.

Which NDCs map to J2790?

The October 2026 ASP crosswalk lists 5 NDCs from 2 labelers: Rhogam (Kedrion Biopharma Inc); HyperRho S/D (Grifols USA, LLC). For example NDC 00562-7805-01 (package size 1) equals 1 billing unit of J2790.

Does J2790 have NCCI bundling edits?

In the v323r0 practitioner PTP file, J2790 appears as the column-2 (bundled) code in 0 active pairs and as the column-1 code in 2. The most frequent column-1 partners are .

J2790 vs J2788: what is the difference?

Both are HCPCS Level II codes whose descriptor names rho d immune globulin. What sets J2788 apart: CMS descriptor names "minidose"; billed per 50 mcg (250 IU). J2790 is billed per 300 mcg (1500 iu), limit $82.081, MUE 1; J2788 is billed per 50 mcg (250 iu), limit $27.653, MUE 1. Report the code whose descriptor matches the product and setting in the record.

J2790 vs J2792: what is the difference?

Both are HCPCS Level II codes whose descriptor names rho d immune globulin. What sets J2792 apart: Winrho SDF from Kamada Ltd.; intravenous route; billed per 100 IU. J2790 is billed per 300 mcg (1500 iu), limit $82.081, MUE 1; J2792 is billed per 100 iu, limit $35.395, MUE 450. Report the code whose descriptor matches the product and setting in the record.

Which Medicare coverage articles mention J2790?

1 current Billing and Coding Article in the Medicare Coverage Database lists J2790, covering 2 states: A57160 (Billing and Coding: Immune Thrombocytopenia (ITP) Therapy).

What diagnosis codes support J2790?

One Medicare billing and coding article lists 1 covered ICD-10-CM code for J2790, for example D69.3 (Immune thrombocytopenic purpura). Each contractor's list applies only in its own jurisdiction, so the claim must carry a code from the article of the contractor that processes it.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.